Laura Lentini

7PUBLICATIONS
24CO-AUTHORS
Molecular targetsReaction engineering (excl. nuclear reactions)Regenerative medicine (incl. stem cells)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 27, 2026
Targeting FTSJ1 to Restore TP53 Function in Nonsense Mutation-Driven Cancer: Computational and Experimental Evaluation of 1,2,4-Triazole Derivatives.

|Jun 06, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview.

Emanuele Vitale, Davide Ricci, Federica Corrao

|May 27, 2025
Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based Innovations.

Davide Ricci, Ilenia Cruciata, Ignazio Fiduccia

|Oct 28, 2023
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression.

Riccardo Perriera, Emanuele Vitale, Ivana Pibiri

|Jun 10, 2023
Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR.

Pietro Salvatore Carollo, Marco Tutone, Giulia Culletta

|Apr 23, 2022
Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome.

Valentino Bezzerri, Laura Lentini, Martina Api

Pageof 2

Frequent Collaborators

4 joint publications

Andrea Pace

4 joint publications

Ivana Pibiri

3 joint publications

Marco Tutone

2 joint publications

Raffaella Melfi